Sign in
4

Changes in Ownership

Anixa Biosciences Inc Filed Acc 0001493152-23-039093

President, COO & CFO acquired 1,117 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Catelani Michael President, COO & CFO 2023-10-31 Grant or award +1,117 $2.69 $3,005 27,772 D: show line 1 in the form
Loading xslF345X05/ownership.xml…